Economic Insider

Business

World’s First AI Vaccine Trial Boosts Biotech Innovation Market Prospects

World’s First AI Vaccine Trial Boosts Biotech Innovation Market Prospects

A vaccine candidate whose key antigen was created using artificial intelligence has completed its first human safety trial, researchers reported June 4, 2026. The Phase I study, conducted at clinical sites in the United Kingdom, showed the experimental vaccine was well tolerated and prompted immune responses against multiple coronaviruses in

World’s First AI Vaccine Trial Boosts Biotech Innovation Market Prospects

World’s First AI Vaccine Trial Boosts Biotech Innovation Market Prospects

A vaccine candidate whose key antigen was created using artificial intelligence has completed its first human safety trial, researchers reported June 4, 2026. The Phase I study, conducted at clinical sites in the United Kingdom, showed the experimental vaccine was well tolerated and prompted immune responses against multiple coronaviruses in

more news articles trending today